What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.78%Above 5Y avg (0.46%)
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
46.7%Sustainable
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.48BCNY
2.32B · vs all stocks (USD)
Updated Oct 20, 2026
Trailing P/E
22.68x
Updated Oct 20, 2026
Revenue (TTM)
6.37BCNY
953.71M · vs all stocks (USD)
Updated Oct 20, 2026
Profit Margin
10.58%
Updated Oct 20, 2026
Beta
0.4210x
vs all stocks
Updated Oct 20, 2026
52-Week Change
-35.28%
vs all stocks
Updated Oct 20, 2026
Forward Annual Dividend Yield
0.78%
vs all stocks
Updated Oct 20, 2026
Market Capitalization
15.48BCNY
2.32B · vs all stocks (USD)
Updated Oct 20, 2026
Enterprise Value
10.89BCNY
1.63B · vs all stocks (USD)
Updated Oct 20, 2026
Trailing P/E
22.68x
Updated Oct 20, 2026
Forward P/E
9.15x
Updated Oct 20, 2026
Price to Sales (TTM)
2.38x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.43×.Updated Oct 20, 2026
Price to Book (MRQ)
1.93x
Updated Oct 20, 2026
Enterprise to Revenue
1.71x
Updated Oct 20, 2026
Enterprise to EBITDA
10.50x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.61×.Updated Oct 20, 2026
Gross Margin
39.29%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 49.3%.Updated Oct 20, 2026
Profit Margin
10.58%
Updated Oct 20, 2026
Operating Margin
14.66%
Updated Oct 20, 2026
Return on Assets (TTM)
7.27%
Updated Oct 20, 2026
Return on Equity (TTM)
8.63%
Updated Oct 20, 2026
Revenue (TTM)
6.37BCNY
953.71M · vs all stocks (USD)
Updated Oct 20, 2026
Revenue per Share (TTM)
3.24CNYUpdated Oct 20, 2026
Quarterly Revenue Growth
34.60%
Updated Oct 20, 2026
Gross Profit (TTM)
3.14BCNY
470.14M · vs all stocks (USD)
Updated Oct 20, 2026
EBITDA (TTM)
1.13BCNY
169.60M · vs all stocks (USD)
Updated Oct 20, 2026
Net Income (TTM)
673.96MCNY
100.91M · vs all stocks (USD)
Updated Oct 20, 2026
Quarterly Earnings Growth (YoY)
-22.10%
Updated Oct 20, 2026
Operating Cash Flow (TTM)
1.24BCNY
185.25M · vs all stocks (USD)
Updated Oct 20, 2026
Levered Free Cash Flow (TTM)
652.60MCNY
97.71M · vs all stocks (USD)
Updated Oct 20, 2026
Forward Annual Dividend Rate
0.0600CNYUpdated Oct 20, 2026
Forward Annual Dividend Yield
0.78%
vs all stocks
Updated Oct 20, 2026
Trailing Annual Dividend Rate
0.0600CNYUpdated Oct 20, 2026
Trailing Annual Dividend Yield
0.76%
vs all stocks
Updated Oct 20, 2026
5-Year Average Dividend Yield
0.46%
vs all stocks
Updated Oct 20, 2026
Payout Ratio
46.69%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 17.65%.Updated Oct 20, 2026
Minority Interest (Equity)
-8.32MCNYFY2025 · Dec 31, 2025
Revenue
5.82BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.46BCNYFY2025 · Dec 31, 2025
Gross Profit
3.36BCNYFY2025 · Dec 31, 2025
Operating Income
1.17BCNY
175.24M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.01BCNYFY2025 · Dec 31, 2025
Income Tax Expense
225.60MCNYFY2025 · Dec 31, 2025
Net Income
786.17MCNYFY2025 · Dec 31, 2025
EBIT
1.02BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.33BCNYFY2025 · Dec 31, 2025
Research & Development
338.48MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
791.11MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
25.65MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
40.68MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.26MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4087CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4080CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.96BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.96BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
786.17MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
15.34MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
868.45MCNYFY2025 · Dec 31, 2025
Free Cash Flow
788.71MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.15BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
786.17MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
56.66MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
9.90MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
15.72MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-79.74MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-32.25MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-6.67BCNYFY2025 · Dec 31, 2025
Sale of Investments
6.27BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-4.68MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-511.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
46.94MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-159.35MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-198.80MCNYFY2025 · Dec 31, 2025
Other Financing Charges
31.32MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-279.89MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.97BSharesUpdated Oct 20, 2026
Float Shares
1.77BSharesUpdated Oct 20, 2026
% Held by Insiders
14.70%
vs all stocks
Updated Oct 20, 2026
% Held by Institutions
8.67%
vs all stocks
Updated Oct 20, 2026
Total Cash (MRQ)
4.36BCNY
652.32M · vs all stocks (USD)
Updated Oct 20, 2026
Total Cash per Share (MRQ)
2.21CNYUpdated Oct 20, 2026
Total Debt (MRQ)
65.82MCNY
9.86M · vs all stocks (USD)
Updated Oct 20, 2026
Total Debt to Equity (MRQ)
0.0083x
Updated Oct 20, 2026
Current Ratio (MRQ)
4.56x
Updated Oct 20, 2026
Book Value per Share (MRQ)
4.00CNYUpdated Oct 20, 2026
Total Assets
8.74BCNY
1.31B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
5.49BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.11BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.25BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
20.74MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.09BCNYFY2025 · Dec 31, 2025
Cash
2.12BCNYFY2025 · Dec 31, 2025
Cash Equivalents
30.99MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.16BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
792.65MCNYFY2025 · Dec 31, 2025
Accounts Receivable
756.95MCNYFY2025 · Dec 31, 2025
Inventory
176.96MCNYFY2025 · Dec 31, 2025
Accounts Payable
420.40MCNYFY2025 · Dec 31, 2025
Short-term Debt
55.67MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
59.69MCNYFY2025 · Dec 31, 2025
Long-term Debt
6.77MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
74.41KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.97BCNYFY2025 · Dec 31, 2025
Retained Earnings
4.64BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
7.64BCNY
1.14B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.83CNYUpdated Oct 20, 2026
52-Week High
13.99CNYUpdated Oct 20, 2026
52-Week Change
-35.28%
vs all stocks
Updated Oct 20, 2026
Beta
0.4210x
vs all stocks
Updated Oct 20, 2026
50-Day MA
8.07CNYUpdated Oct 20, 2026
200-Day MA
9.32CNYUpdated Oct 20, 2026
Avg 10-Day Volume
31.63MSharesUpdated Oct 20, 2026
Avg 30-Day Volume
31.41MSharesUpdated Oct 20, 2026
Diluted EPS (TTM)
0.3400CNYUpdated Oct 20, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.79: safe zoneNotable
Altman Z-Score: 10.79
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.32B, above the global median of $1.15BNotable
Market cap (USD): 2,317,913,884.419Global Median: 1,150,342,212.262
Revenue is $953.71M, above the global median of $559.35MNotable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration